Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
Bm T
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
| Legal entity | DeepEn GmbH | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Manifold Bio has built the first high-throughput in vivo (HTV) discovery engine—combining massively multiplexed in vivo screening and…

PIRAMIDAL. Bridge in-vivo with in-silico intelligence.

Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.

Developing scalable in-vivo genomic medicine for blood disorders.

High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.

微滔生物成立于2025年6月25日,其前身系沙砾集团为自主研发的体内CAR-T平台独立运营而成。微滔生物将基于T 靶向 LNP 递送系统开发in vivo CAR-T管线,专注于非病毒体内靶向细胞治疗业务,该业务主要用于血液瘤及自身免疫疾病治疗。.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Jena
Germany
Registered seat
1-10 est. staff

Bm T 



